A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults

NCT06783114 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
254
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chongqing Claruvis Pharmaceutical Co., Ltd.